Cyclooxygenase‐2 deficient mice are resistant to endotoxin‐induced inflammation and death
- 8 May 2003
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 17 (10) , 1325-1327
- https://doi.org/10.1096/fj.02-1078fje
Abstract
Sepsis is a systemic inflammatory response to a blood-borne infection that is associated with an extremely high rate of morbidity and mortality. The present study investigates the role of cyclooxygenase (COX)-2 in host responses to bacterial endotoxemia. After administration of Escherichia coli lipopolysaccharide, 50% of wild-type mice die within 96 h. COX-2 deficient mice displayed a dramatic improvement in survival with reduced leukocyte infiltration into critical organs (kidneys and lungs) and a blunted and delayed induction of the cytokine inducible genes nitric oxide synthase 2 and heme oxygenase-1. Translocation and activation of transcription factors important for signaling events during an inflammatory response, such as nuclear factor (NF)-kappaB, were also markedly reduced. While the absence of COX-2 did not alter the induction of several pro-inflammatory cytokines in tissue macrophages, induction of the anti-inflammatory cytokine IL-10 was exaggerated. Administration of IL-10 to wild-type mice reduced NF-kappaB activation. Taken together, our data suggest that COX-2 deficient mice are resistant to many of the detrimental consequences of endotoxemia. These beneficial effects occur, in part, by a compensatory increase in IL-10 that counterbalances the pro-inflammatory host response to endotoxemia.Keywords
Funding Information
- National Institutes of Health (GM53249, HL60788)
This publication has 48 references indexed in Scilit:
- Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in miceNature Medicine, 2002
- What is the role of interleukin 10 in polymicrobial sepsis: Anti-inflammatory agent or immunosuppressant?Surgery, 1999
- Interactions between inducible isoforms of nitric oxide synthase and cyclo‐oxygenase in vivo: investigations using the selective inhibitors, 1400W and celecoxibBritish Journal of Pharmacology, 1998
- Induction of Heme Oxygenase-1 Expression in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 1997
- Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized miceGastroenterology, 1996
- Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase IINature, 1995
- Search for Sepsis Drugs Goes on Despite Past FailuresScience, 1994
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.The Journal of Experimental Medicine, 1993
- β-VLDL-induced alterations in growth potentiating activity produced by mononuclear phagocytesAtherosclerosis, 1988